首页> 外文期刊>Pharmacological research: The official journal of The Italian Pharmacological Society >Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals
【24h】

Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals

机译:迷迭香植物化学物质对抗癌药物外流转运蛋白P-糖蛋白的抑制作用

获取原文
获取原文并翻译 | 示例
       

摘要

The effects of dietary antioxidative and chemopreventive rosemary phytochemicals on the function of the human drug efflux transporter P-glycoprotein (MDR1, ABCB1) and multidrug resistance protein 1 (MRP1, ABCC1) were investigated using P-glycoprotein-overexpressing human carcinoma KB-C2 cells and human MRP1 gene-transfected KB/MRP cells. The effects of natural phytochemicals found in rosemary such as carnosic acid, carnosol, rosmarinic acid, and ursolic acid were investigated. The accumulation of daunorubicin or rhodamine 123, fluorescent substrates of P-glycoprotein, in KB-C2 cells increased in the presence of carnosic acid, carnosol, and ursolic acid in a concentration-dependent manner. In contrast, carnosic acid, carnosol, rosmarinic acid, and ursolic acid had no effects on the accumulation of calcein, a fluorescent substrate of MRP1, in KB/MRP cells. The ATPase activities of P-glycoprotein were stimulated by carnosic acid, carnosol, and ursolic acid. KB-C2 cells were sensitized to vinblastine cytotoxicity by carnosic acid, showing that carnosic acid reverses multidrug resistance. These results suggest that rosemary phytochemicals, such as carnosic acid, have inhibitory effects on anticancer drug efflux transporter P-slycoprotein and may become useful to enhance the efficacy of cancer chemotherapy.
机译:使用过表达P-糖蛋白的人癌KB-C2细胞研究了膳食抗氧化和化学预防迷迭香植物化学物质对人药物外流转运蛋白P-糖蛋白(MDR1,ABCB1)和多药耐药蛋白1(MRP1,ABCC1)功能的影响和人类MRP1基因转染的KB / MRP细胞。研究了迷迭香中天然的植物化学物质,如肌酸,肌醇,迷迭香酸和熊果酸的影响。在肌酸,肌醇和熊果酸的存在下,柔红霉素或罗丹明123(P-糖蛋白的荧光底物)在KB-C2细胞中的积累以浓度依赖的方式增加。相反,肌酸,肌醇,迷迭香酸和熊果酸对钙黄绿素(KB / MRP细胞)中钙黄绿素(MRP1的荧光底物)的积累没有影响。肌酸,肌醇和熊果酸刺激P-糖蛋白的ATP酶活性。肌酸使KB-C2细胞对长春碱的细胞毒性敏感,表明肌酸可逆转多药耐药性。这些结果表明迷迭香植物化学物质,例如肌酸,对抗癌药物外排转运蛋白P-糖蛋白具有抑制作用,并且可能用于增强癌症化学疗法的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号